Drug intelligence / Profile preview

chlormadinone

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral
01

Overview

Chlormadinone is a synthetic progestin and antiandrogen used primarily in combination with estrogens for oral combined hormonal contraceptive therapy. It acts as an agonist of the progesterone receptor and as an antagonist of the androgen receptor. Its main clinical uses are in contraception, menopausal hormone therapy, and treatment of gynecological disorders. Chlormadinone is also used to treat androgen-dependent conditions such as acne and hirsutism in women and benign prostatic hyperplasia or prostate cancer in men. The drug suppresses ovulation by inhibiting gonadotropin secretion, thickens cervical mucus to prevent sperm penetration, reduces endometrial thickness, and exhibits moderate antiandrogenic activity[1][3][8]. It is available both alone (in some countries) or more commonly as its acetate ester form (chlormadinone acetate), often combined with ethinylestradiol for contraception.

Brand names
ChlormadinonumChlormadinonClormadinona
Other names
chlormadinonechlormadinonum (Latin)chlormadinon (German)clormadinona (Spanish)pregna-4,6-diene-3,20-dione, 6-chloro-17-hydroxy-
02

Targets

PR (Progesterone receptor)GR (Glucocorticoid receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on chlormadinone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlormadinone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call